Search

Search Constraints

You searched for: Author/Creator Lecomte, T.

Search Results

2. 2228 Gastric neuroendocrine tumors (NETs): Data from the national French cohort of the Groupe d'Etude des Tumeurs Endocrines (GTE), CARGAS study. (September 2015)

3. 2349 Phase 1b/2 study results for masitinib plus irinotecan in second-line treatment of esophagogastric adenocarcinoma. (September 2015)

4. 2355 Nab-paclitaxel plus gemcitabine or plus simplified LV5FU2 as first- line therapy in patients with metastatic pancreatic adenocarcinoma. A GERCOR randomized phase II study (AFUGEM). (September 2015)

5. 714PGemcitabine and platinum- based chemotherapy in first line treatment of hepatocholangiocarcinoma: An AGEO multicenter retrospective study. (18th September 2017)

6. FOLFIRINOX as induction treatment in rectal cancer patients with synchronous metastases: Results of the FFCD 1102 phase II trial. (November 2018)

7. Geriatric analysis from PRODIGE 20 randomized phase II trial evaluating bevacizumab + chemotherapy versus chemotherapy alone in older patients with untreated metastatic colorectal cancer. (July 2018)